QazCovid-in

QazCovid-in
Butiran vaksin
Penyakit sasaran	SARS-CoV-2
Jenis	Tidak aktif
Data klinikal
Kaedah; pemberian	Intraotot

QazCovid-in merupakan calon vaksin COVID-19 yang dikembangkan oleh Institut Penyelidikan untuk Masalah Keselamatan Biologi di negara Kazakhstan.^[1]^[2]^[3]

Rujukan sunting

^ Yergaliyeva A (20 December 2020). "Kazakhstan Begins Vaccinating 3,000 Volunteers With Self-Made QazCovid-in". The Astana Times. Dicapai pada 2 March 2021.
^ Clinical trial number NCT04691908 for "Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine" at ClinicalTrials.gov
^ "Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine - Full Text View - ClinicalTrials.gov". clinicaltrials.gov.

Pautan luar sunting

Scholia mempunyai profil tentang QazCovid-in (Q99518269).

[1] Yergaliyeva A (20 December 2020). "Kazakhstan Begins Vaccinating 3,000 Volunteers With Self-Made QazCovid-in". The Astana Times. Dicapai pada 2 March 2021.

[QazCov3-2] Clinical trial number NCT04691908 for "Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine" at ClinicalTrials.gov

[3] "Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine - Full Text View - ClinicalTrials.gov". clinicaltrials.gov.

[1]

[2]

[3]